The Chefs' Warehouse (CHEF) Q4 2025 earnings review
Organic Engine Firing on All Cylinders, Despite 'Noise'
Chefs' Warehouse closed FY25 with a definitive acceleration in topline growth (+10.5%), driven primarily by a robust 9.7% organic sales increase. The narrative is bifurcated: the core Specialty category is thriving (margins +45 bps), while the Center-of-the-Plate (protein) segment drags due to commodity exits and deflation. While GAAP Net Income fell 9.2% due to an $8M asset impairment charge, the underlying profitability is strong—Adjusted EBITDA surged 17.7%. FY26 guidance implies a cooling off to ~6% growth, suggesting management is starting the year conservatively.
🐂 Bull Case
Organic sales growth accelerated to 9.7% in Q4 (up from prior trend), fueled by a 4.2% increase in unique item placements. The company is successfully penetrating existing accounts despite a noisy macro environment.
The core Specialty category saw gross margins expand 45 basis points. As the mix shifts further toward these higher-margin items and away from commodity proteins, structural profitability improves.
🐻 Bear Case
The protein segment is a dead weight on optics. Organic pounds sold fell 2.4% and margins compressed 50 basis points. While management cites exiting 'non-core' programs, this segment is actively diluting company-wide gross margins (-8 bps total).
After delivering 10.5% growth in Q4, FY26 guidance ($4.35-$4.45B) implies roughly 6% growth at the midpoint. Investors betting on a continued double-digit trajectory may be disappointed by the conservative outlook.
⚖️ Verdict: 🟢
Bullish. The underlying engine—organic specialty volume—is accelerating. The GAAP earnings miss is entirely due to a one-time impairment cleanup. Once the 'non-core' protein exit is fully lapped, the P&L will look significantly cleaner.
Key Themes
Impairment Charge Hits GAAP Earnings
GAAP Net Income fell 9.2% YoY, creating a headline miss. This was caused by an $8.0 million impairment charge on a 'non-core customer relationship intangible asset.' While one-time in nature, it signals a messy breakup with a significant legacy arrangement.
Specialty Category Strength
This segment remains the crown jewel. Organic case count rose 3.3%, and gross margins expanded 45 basis points. The company successfully pushed unique item placements (+4.2%), validating the 'hunter' sales model effectiveness even in a mature market.
Protein Segment Rationalization
The Center-of-the-Plate category is shrinking by design but hurting margins in the interim. Organic pounds sold dropped 2.4% due to the exit of a non-core commodity poultry program. Gross margins in this segment fell 50 basis points, dragging the consolidated gross margin down to 24.2% (-8 bps YoY).
Operating Leverage
Despite SG&A expenses rising 8.9% in dollar terms, they fell as a percentage of sales (19.7% vs 20.0% last year). Adjusted EBITDA margin expanded to 7.0% from 6.6% a year ago, proving the company can squeeze efficiency out of its distribution network even while investing in fleet and facilities.
Other KPIs
Accelerating. This is a strong beat against the total sales growth of 10.5%, implying that acquisitions were a minor contributor (0.8%) and the core business is driving the ship. This is the highest organic growth rate of the fiscal year.
Accelerating. Up 17.7% YoY. The margin expansion to 7.0% (up 40 bps YoY) demonstrates that the drop in Gross Margin was more than offset by SG&A leverage.
Decelerating. Down from $153.1M in FY24. This was driven by a larger build in Working Capital—Inventories rose by $67M this year compared to a $32M rise last year, likely to support the holiday season and new facility ramps.
Guidance
Decelerating. The midpoint ($4.4B) implies ~6.0% YoY growth, a significant step down from the 10.5% pace seen in Q4 and the ~9% seen for full year FY25. This likely reflects conservatism regarding the macro environment or the annualized impact of the protein program exit.
Stable. The midpoint ($281M) implies ~8.8% growth over FY25's $258.3M. While positive, it lags the double-digit EBITDA growth delivered in recent quarters. Implicit margin is ~6.4%, effectively flat vs FY25.
Key Questions
Impairment Details
Regarding the $8.0M impairment on the 'non-core customer relationship'—was this a forced exit or a strategic choice, and are there further 'non-core' assets at risk of write-down in FY26?
Protein Segment Stabilization
With the exit of the commodity poultry program impacting volumes (-2.4%) and margins (-50 bps), when do you expect the Center-of-the-Plate segment to return to positive volume growth and margin stability?
Inventory Build
Inventory usage was a $67M headwind to operating cash flow in FY25 (double the prior year). Is this a structural requirement for the new distribution centers, or should we expect a release of working capital in FY26?